Pembrolizumab Combo

Pembrolizumab Combo: A Game-Changer for HER2+ Gastric Cancer Patients in the EU

CHMP Backs Approval of Pembrolizumab Combination Therapy for HER2+ Gastric Cancer in the EU

SG Tylor

Source – Merck A new combination therapy for patients with advanced gastric or GEJ cancer that is positive for both ...